Dysport 500 U injection
PDF Leaflet Revision Date: 28 June 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic treatment of focal spasticity and cosmetic improvement of facial lines.
Dosage (summary)
Paediatric: 15-30 units/kg; Adults: max 1000 units/session.
Onset of Action / Duration
Onset: 2 weeks, Duration: up to 20 weeks.
Special Populations
- Elderly
- Paediatric patients (u22652 years)
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation.
Key Drug Interactions
- Aminoglycosides
- Muscle relaxants
Contraindications
- Hypersensitivity
- Infection at injection site
- Pregnancy
- Lactation
Common side effects
- Muscle weakness
- Dysphagia
- Injection site reactions
Counselling Points
- Seek immediate help for swallowing or breathing issues.
- Avoid driving if experiencing muscle weakness or visual disturbances.
Serious warnings
- Risk of distant spread of toxin
- Caution in neuromuscular disorders
Important Disclaimer
The Dysport 500 U injection professional information leaflet below is the property of Acino Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
